Inhibiton of NF-κB activity with dexamethasone enhanced apoptosis induced by chemotherapeutic drugs in human leukemic cell line

许小平,史剑慧,吕书晴,费新红,张劲松,张宗梁,程文英

DOI: https://doi.org/10.3969/j.issn.0253-9934.2003.06.004

2003-01-01

Abstract:Objective To analyze the relationship between activation of nuclear factor κB(NF κB) and apoptosis of leukemic cells induced by chemotherapeutic drugs and to explore the influence of dexamethasone (DXM). Methods Electrophoretic mobility shift assay (EMSA) was used to detect the activation of NF κB, TUNEL was adopted to observe apoptosis induced by homoharringtonine (HH) and etopside (VP 16) in HL60 n leukemic cells. Results The activation of NF κB induced by HH and VP 16 was obviously correlated to apoptosis induced by chemotherapeutic drugs in HL60 n cells. DXM(1 μmol/L) could inhibit activation of NF κB(suppressed by 57.5% and 37.2%, respectively), and increase significantly the apoptosis (increased by 49.69% and 44.35%, respectively), induced by HH(0.5 μmol/L)or VP 16 (1 μmol/L). Before exposed to chemotherapeutic agents, the activity of NF κB could be found in HL60 n cells. Conclusion Chemotherapeutic drugs induce apoptosis, and activation of NF κB of HL60 n cells. DXM enhances apoptosis on leukemic cells induced by chemotherapeutic drugs, which may be related to suppression of the activation of NF κB.